Cell line · CVCL_F936
B16
Cancer cell line, Mus musculus. Mouse melanoma. 28 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. B16. Cell lines, record CVCL_F936. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_F936
On this page
Cell line
As Cellosaurus gives it.
- Name
- B16
- Accession
- CVCL_F936
- RRID
- RRID:CVCL_F936
- Synonyms
- B-16, B16 melanoma, B16 subline B78, B78
- Species
- Mus musculus (Mouse)
- Sex
- Male
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Mouse melanoma (NCIt C21790)
- Derived from
- Skin (in situ)
- Parent
- HFH-18 (CVCL_GS32)
- Entry created
- 2013-02-11
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers28
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Stimulate-and-retain hydrogel strategy integrating oncolytic virus and oxaliplatin for dual ICD-inducing antitumor immunity. | Acta Pharm Sin B | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Rose-derived extracellular vesicle-like particles enable anti-melanogenesis by suppressing the key melanogenic pathway in skin cells. | Extracell Vesicles Circ Nucl Acids | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Covalent Inhibition of SHMT2 by Gambogic Acid Induces Ferroptosis Through Mitochondrial Collapse in Triple-Negative Breast Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatially programmed Fe and Pt electrode-driven electrochemistry reconditions the tumor microenvironment and sensitizes triple-negative breast cancer to PD-1 Blockade. | Front Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Autophagy-enhanced hybrid pyroptotic vesicles as personalized vaccines for cancer immunotherapy. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Galangin-loaded biomimetic dendritic cells membrane nanovaccine reprograms the ovarian cancer microenvironment via Stat3/IDO1/AhR axis to boost immunotherapy. | Mater Today Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| 5G RF-EMFs Mitigate UV-Induced Genotoxic Stress Through Redox Balance and p38 Pathway Regulation in Skin Cells. | Antioxidants (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer cachexia-related monocytic myeloid-derived suppressor cells impair T-cell negative selection and predict immune-related adverse events. | Liver Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TSH Ligand-Based CAR-T Cell Effectively Eradicates TSHR-Positive Thyroid Cancer with Favorable Safety Profile. | Adv Sci (Weinh) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| The immune response against cancer is modulated by stromal cell fibronectin. | Neoplasia | 2025 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 28
See all 28 papersRelatives24
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | HFH-18 | CVCL_GS32 | Cell lines | |
| Derived from it | B16 melanoma 4A5 | CVCL_4612 | Cell lines | |
| Derived from it | B16 melanoma/lacZ | CVCL_L291 | Cell lines | |
| Derived from it | B16-A | CVCL_8298 | Cell lines | |
| Derived from it | B16-B | CVCL_8299 | Cell lines | |
| Derived from it | B16-C2M | CVCL_H720 | Cell lines | |
| Derived from it | B16-C2W | CVCL_H721 | Cell lines | |
| Derived from it | B16-F0 | CVCL_0604 | Cell lines | |
| Derived from it | B16-MO4 | CVCL_WM78 | Cell lines | |
| Derived from it | B16-MO5 | CVCL_WM77 | Cell lines |
1 to 10 of 24
See all 24 relativesCell banks8
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| CLS | 305154 | CLS | |
| Hysigen | TCM-C712 | Hysigen | |
| JCRB | JCRB0202 | JCRB | |
| KCB | KCB 2014029YJ | Cellosaurus | |
| KCB | KCB 93030YJ | Cellosaurus | |
| NCI-DCTD | B16 | Cellosaurus | |
| RCB | RCB1283 | RCB | |
| TKG | TKG 0144 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_F936
GET https://conductscience.org/api/cell-lines/v1/CVCL_F936/papers?page=2